糖尿病周围神经病变在神经缺血性足部创面初次膝下血管成形术中的临床意义
回顾性分析2009至2019年304例因神经缺血性Rutherford 5级足部创面行初次膝下血管成形术的糖尿病缺血肢体,按振动感知阈值分为神经病变正常、轻中度和重度三组。重度组初次成功率68%、36个月一期通畅率35%、创面愈合率36%、保肢率54%,均低于其他两组且差异显著,但总体生存无显著差异。
要点
- 重度糖尿病周围神经病变组36个月一期通畅率35%、创面愈合率36%、保肢率54%。
- 重度组与正常组及轻中度组在通畅率、组织愈合和保肢方面差异显著。
- 三组间总体生存率无显著差异(p=0.34)。
核心结论
- 重度糖尿病周围神经病变可能损害膝下血管成形术在通畅性、组织愈合和保肢方面的结果,但对患者生存无显著影响。
- 作者认为,存在糖尿病周围神经病变时需将其作为慢性肢体威胁性缺血治疗的特定指标进行适当分层。
研究设计与样本
- 回顾性研究,纳入2009至2019年10年间304例因神经缺血性Rutherford 5级足部创面行初次膝下血管成形术的糖尿病缺血肢体。
- 所有患者进行下肢振动感知阈值诊断以评估糖尿病周围神经病变,并按0至10分进行评分。
- 按评分分为三组:0-1分为正常组(组1,19%肢体),2-6分为轻中度神经病变组(组2,55%肢体),7-10分为重度糖尿病周围神经病变组(组3,26%肢体)。
- 治疗动脉病变平均长度为6.1 cm(范围1-22 cm)。
主要发现
- 初次膝下血管成形术成功率:组1为89%,组2为82%,组3为68%。
- 组3在36个月时临床获益最低:一期通畅率35%(95%CI=22%至48%),创面愈合率36%(95%CI=22%至50%),保肢率54%(95%CI=39%至69%)。
- 组1与组3比较:一期通畅率p=0.014,组织愈合p=0.049,保肢p=0.006,差异显著。
- 组2与组3比较:一期通畅率p=0.043,组织愈合p=0.01,保肢p=0.023,差异显著。
- 组1与组2比较无统计学差异(p>0.05);三组间总体生存无显著差异(p=0.34)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the clinical effects of diabetic peripheral neuropathy (DPN) in patients with chronic limb-threatening ischemia (CLTI) treated by primary infrapopliteal angioplasty for neuro-ischemic Rutherford 5, foot wounds. MATERIALS AND METHODS: Over a 10-year period (2009-2019), a series of 304 diabetic ischemic limbs adding or not evincible neuropathic affectation were treated by primary infrapopliteal angioplasty and their files were retrospectively reviewed. Mean length of treated arterial lesions was 6.1 cm (range 1-22 cm). Inferior limb vibration perception threshold diagnostic was performed for comparing and scoring detectable DPN in all studied diabetic patients (classed from 0 to 10 points). There were 19% limbs with normal (0-1 points) perception (group 1), 55% others with "mild" and "moderate" (2-6 points) neuropathic impairment (group 2), and 26% limbs showing "severe" (7-10 points) DPN (group 3). RESULTS: Primary infrapopliteal angioplasty succeeded in 89% cases in group 1, in 82% in group 2, and in 68% of limbs in group 3. This latest group assembled the heaviest neuropathic affectation and arterial calcifications and proved the lowest clinical benefit at 36 months: 35% (95% confidence interval [CI]=22% to 48%) of primary patency, 36% (95% CI=22% to 50%) wound healing, and 54% (95% CI=39% to 69%) limb preservation rates. A comparison between groups 1 vs 3 and 2 vs 3 of primary patency (p=0.014 and p=0.043), tissue healing (p=0.049 and p=0.01), and limb salvage (p=0.006 and p=0.023) proved significant, yet without statistical weight for group 1 vs 2 (p>0.05). Overall survival was not significantly affected between groups (p=0.34). CONCLUSION: The presence of severe DPN may jeopardize the results of infrapopliteal angioplasty in terms of patency, tissue cicatrization, and limb preservation, yet without significance on survival of these patients. When present, DPN requires appropriate stratification as specific indicator in CLTI treatment.
引用
- Alexandrescu VA, Van Overmeire L, Makrygiannis G, et al. Clinical Implications of Diabetic Peripheral Neuropathy in Primary Infrapopliteal Angioplasty Approach for Neuro-Ischemic Foot Wounds. J Endovasc Ther. 2022. PMID: 35786131. doi:10.1177/15266028221106312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。